Skip to main content
SpringerLink
Log in

Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research

  • CORRESPONDENCE
  • Published:
Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

No datasets were generated or analysed during the current study.

References

  1. Barbhaiya M, Zuily S, Naden R, et al. ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023. https://doi.org/10.1002/art.42624.

    Article  PubMed  Google Scholar 

  2. Carbone T, Infantino M, Antico A, et al. An Italian nationwide survey on the evolution of autoantibody diagnostics in autoimmune rheumatic diseases. Clin Exp Rheumatol. 2023. https://doi.org/10.55563/clinexprheumatol/bhnk4l.

    Article  PubMed  Google Scholar 

  3. Lakos G, Favaloro EJ, Harris EN, et al. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum. 2012;64(1):1–10. https://doi.org/10.1002/art.33349.

  4. Tebo AE, Willis R, Nwosu A, et al. Reporting and establishment of reference intervals for antiphospholipid antibody immunoassays: A survey of participants in the college of american pathologists proficiency testing program [published online ahead of print, 2023 Sep 26]. Arch Pathol Lab Med. 2023. https://doi.org/10.5858/arpa.2023-0095-CP.

    Article  PubMed  Google Scholar 

  5. Damoiseaux J. The perspective on standardisation and harmonisation: the viewpoint of the EASI president. Auto Immun Highlights. 2020;11:4. https://doi.org/10.1186/s13317-020-0127-3.

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

    Xiaochun Susan Zhang

  2. Case Western Reserve University, School of Medicine, Cleveland, OH, USA

    Xiaochun Susan Zhang

  3. Clinical Pathology, Azienda Sanitaria Universitaria Integrata, Udine, Italy

    Nicola Bizzaro

  4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

    Anne E. Tebo

  5. University of Utah School of Medicine and ARUP Laboratories, Salt Lake City, UT, USA

    Vijayalakshmi Nandakumar

  6. Laboratory of Immunology and Allergy, San Giovanni di Dio Hospital, Florence, Italy

    Maria Infantino

  7. Immunopathology Laboratory, Regional San Carlo Hospital, Potenza, Italy

    Teresa Carbone

  8. Laboratory Medicine, UZ Leuven and Clinical and Diagnostic Immunology, KU Leuven, Louvain, Belgium

    Xavier Bossuyt

  9. Central Diagnostic Laboratory, University Medical Center, Maastricht, The Netherlands

    Jan Damoiseaux

Authors
  1. Xiaochun Susan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola Bizzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne E. Tebo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vijayalakshmi Nandakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Infantino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Teresa Carbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xavier Bossuyt
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jan Damoiseaux
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors participated in writing or editing the letter. All authors have reviewed and approved the letter.

Corresponding author

Correspondence to Xiaochun Susan Zhang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dr. Anne Tebo is an inbound liaison representing the Association of Medical Laboratory Immunologists (AMLI) to the College of American Pathologists’ Diagnostic Immunology and Flow Cytometry Committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X.S., Bizzaro, N., Tebo, A.E. et al. Discouraging Non-ELISA antiphospholipid antibody assays in antiphospholipid syndrome classification may hinder clinical research. Immunol Res (2023). https://doi.org/10.1007/s12026-023-09443-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12026-023-09443-8

Search

Navigation